IBIO News and Press, iBio Inc. From 03/27/24

– Leading AI and precision biologics innovators to build a diverse set of novel best-in-class obesity treatments – – iBio to use its patented generative AI/Machine Learning platform to discover, engineer and develop obesity-focused therapeutic targets – ...

2024-03-27 03:13:31 ET More on iBio iBio stock jumps on sale of preclinical PD-1 agonist antibody program Financial information for iBio Read the full article on Seeking Alpha For further details see: iBio announces $15 million private placement

– Purchase price of $2.85 represents a premium of 148+% to last close – BRYAN, Texas and SAN DIEGO, March 26, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody immunotherapies,...

– Deal includes $1 million upfront and potential future milestone payments – – iBio’s proprietary therapeutic pipeline will now be comprised entirely of promising immuno-oncology candidates – BRYAN, Texas and SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSW...

BRYAN, Texas and SAN DIEGO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody immunotherapies, announced today that Matthew P. Greving Ph.D ., its Vice President and Head of Platform Te...

2023-12-26 07:36:00 ET More on iBio iBio prices 2.25M shares at $2.00 in public offering Financial information for iBio For further details see: iBio to extend maturity date of credit facility

– Extends maturity date to March 29, 2024 – – Allows for more time to complete planned divestiture of legacy CDMO business - BRYAN, Texas and SAN DIEGO, Dec. 26, 2023 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company ...

2023-12-07 08:32:42 ET Losers: Troika Media Group TRKA -71% announces chapter 11 filing and sale to Blue Torch . Phio Pharmaceuticals Corp ( PHIO ) -48% announces exercise of warrants for $2.8 Million gross proceeds . ZyVersa Therapeutics ZVSA -46% on ...

2023-12-06 08:32:51 ET MicroAlgo ( MLGO ) +57% announced plans to establish a practice base to train graduate students for the university Pharvaris ( PHVS ) +38% surges on mid-stage success for hereditary angioedema therapy. ZyVersa Therapeutics  ( ZVSA ...

2023-12-05 12:36:51 ET More on Mid-day movers stocks. Meiwu technology company limited received nasdaq delisting determination Seeking Alpha’s Quant Rating on NuZee, Inc. Historical earnings data for NuZee, Inc. Financial information for NuZee, Inc. ...